How to Choose a Hematology Analyzer for a Clinical Laboratory
Explore key factors in selecting a hematology analyzer, from CBC parameters and workflow to validation, quality control, and total cost of ownership.
Introduction
A hematology analyzer is a foundational instrument in many clinical laboratories. It supports complete blood count (CBC) testing and, depending on the model, may provide white blood cell differentials, reticulocyte analysis, and additional cellular parameters. Because CBC results inform a broad range of clinical decisions, instrument selection deserves more attention than a comparison of throughput claims or purchase prices.
The right solution depends on the laboratory’s test menu, sample profile, staffing, available space, and quality requirements. A small outpatient laboratory and a high-volume hospital laboratory may need different levels of automation even when both perform routine CBC testing.
Understand Your Testing Requirements
Begin with a realistic review of current and projected daily
sample volumes. Document peak-hour demand, urgent samples, expected growth, and
any specialist testing that may be introduced. Nominal throughput, typically
expressed as samples per hour, is useful—but real-world productivity also
depends on reruns, reflex testing, quality-control procedures, and manual
review.
Review the clinical parameters required by your users. A
basic CBC may be sufficient for some services. Others may require a five-part
white cell differential, reticulocyte parameters, immature cell flags, or
dedicated body-fluid capabilities. These features should be checked against the
intended-use documentation for each specific instrument.
Evaluate Analytical Performance, Not Just Features
Precision, accuracy, carryover, linearity, reportable range,
and agreement with existing methods are central evaluation criteria.
Performance requirements should be appropriate for the assays and the patient
population served. A manufacturer’s brochure is a starting point; local
verification remains essential before patient results are released.
The International Council for Standardization in Haematology
(ICSH) emphasizes evaluating hematology analyzers and understanding their
performance and limitations. This includes the value and boundaries of
automated cell classification and digital imaging. Laboratories should
establish procedures for reviewing instrument flags and deciding when
blood-smear examination is required.
Consider Workflow and Automation
Instrument usability affects daily operations. Evaluate
sample loading, barcode identification, cap-piercing options, reagent handling,
onboard storage, automated rerun functions, and maintenance requirements. Ask
how the instrument manages urgent samples without unnecessarily interrupting
the routine workflow.
Connectivity also matters. Integration with a laboratory
information system (LIS) can reduce manual transcription and support
traceability, but interface compatibility and validation should be confirmed.
For laboratories planning future expansion, assess whether the analyzer can
operate within a broader automated workflow.
Plan for Quality Control and Maintenance
The instrument is only one part of a reliable testing
system. Quality-control materials, calibrators, reagent stability,
environmental requirements, and documented procedures must all be considered.
Laboratories need defined action limits and processes for investigating failed
controls before reporting patient results.
Compare routine maintenance tasks, expected downtime, access
to technical support, service response arrangements, and staff training. A low
acquisition price may not compensate for operational disruption if consumables,
spare parts, or technical assistance are difficult to obtain.
Calculate the Total Cost of Ownership
Request a cost model that includes the instrument, reagents,
controls, calibrators, consumables, maintenance, service agreements, waste
handling, and training. Estimate reagent consumption using actual workload
rather than assuming continuous operation at maximum throughput.
A practical procurement exercise compares cost per
reportable result, not just cost per test performed. Quality-control runs,
repeat analyses, expiry-related wastage, and instrument downtime can materially
affect the calculation.
A Practical Selection Checklist
Before selecting a hematology analyzer, ask: Does it cover
the required CBC and differential parameters? Is its throughput suitable for
both average and peak workloads? What local performance verification is needed?
How are abnormal flags reviewed? Are LIS integration and barcode workflows
supported? What training and service arrangements are available? What is the
estimated cost per reportable result?
A documented comparison against these questions makes the final decision
more transparent and easier to justify to clinical, technical, and procurement
teams
Conclusion
The best hematology analyzer is not necessarily the one with
the most parameters or the highest stated throughput. It is the system that
delivers fit-for-purpose performance within a dependable laboratory workflow,
supported by appropriate quality assurance and service.
LUXMED works with clinical laboratories evaluating medical
and laboratory technology solutions. Contact the team to discuss operational
requirements and request information about suitable equipment options. Product
specifications and availability should be confirmed for the proposed model.
Frequently Asked Questions
What is the difference between a three-part and five-part hematology analyzer?
The distinction generally refers to how white blood cell populations are differentiated. The appropriate choice depends on the laboratory’s clinical use, performance requirements, and review workflow.
Is a higher sample-per-hour rating always better?
No. Effective throughput depends on reruns, sample mix, workflow, quality control, and staffing, not only the manufacturer’s nominal rating.
Does a new analyzer require local verification?
Yes. Laboratories should verify relevant performance claims and the suitability of the testing system for their intended use before reporting patient results.
References and editorial sources
- ICSH, Guidelines for the evaluation of blood cell analysers (2014) — https://pubmed.ncbi.nlm.nih.gov/24666725/
- CDC, About Laboratory Quality — https://www.cdc.gov/lab-quality/php/about/
Need help choosing equipment?
Our experts will help you find the right solution for your laboratory.
Get a Consultation
